Congress Urges Medicare to Monitor Use of AI in Prior Authorization

June 25, 2024

United StatesU.S. Congress

Summary

In a letter to the Centers for Medicare & Medicaid Services (CMS), more than 50 lawmakers in both the House and Senate expressed concern that Medicare Advantage plans are using AI in a way that results in denying care erroneously and contradicting provider assessment findings. They urge CMS to proactively monitor plan use of AI-driven tools and require a higher burden of proof for denying coverage of care when AI is used.

Share This Page

AI Law & Regulation Tracker

Access to the latest in AI across regulatory developments, legal and policy issues, and industry news.

Akin Intelligence Newsletter

Subscribe to Akin Intelligence, our monthly newsletter recapping the latest in AI and its impact on various sectors. 

© 2025 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.